U.S. flag An official website of the United States government
  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Generic Drug User Fee Amendments
  5. GDUFA III Reauthorization Negotiation Sessions
  1. Generic Drug User Fee Amendments

GDUFA III Reauthorization Negotiation Sessions

In accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act), the Food and Drug Administration (FDA) held negotiations with the generic drug industry on the reauthorization of the Generic Drug User Fee Amendments of 2017 (GDUFA) program. The FDA publishes all negotiation meeting minutes on this website.

FDA-Industry Negotiations Meeting Minutes

2021

2020

 

 
Back to Top